# Cholangitis

- Category: chronic
- Review status: reviewed (every claim checked against a document named on this page)
- Sources: Cholangitis - StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK558946/ · ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class DD82.00 - condition scope only, no dose · Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis (J Hepatobiliary Pancreat Sci 2018;25:3-16, tokyo-guidelines-2018-antimicrobial-jhbp518.pdf) · Egyptian National Drug Formulary - Antimicrobial 2023 (ceftriaxone monograph, p255)
- Verified date: 2026-08

## Verified against

- Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis (J Hepatobiliary Pancreat Sci 2018;25:3-16, tokyo-guidelines-2018-antimicrobial-jhbp518.pdf)
- Egyptian National Drug Formulary - Antimicrobial 2023 (ceftriaxone monograph, p255)

## Treatment metadata

- Ceftriaxone — 1000 mg — injection
- Referral & safety-netting (no drug therapy)

## Complete treatment card

```text
CHOLANGITIS
Sources: Cholangitis - StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK558946/ · ICPC-3 (WONCA
         International Classification of Primary Care, 3rd edition) class DD82.00 - condition scope
         only, no dose · Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and
         cholecystitis (J Hepatobiliary Pancreat Sci 2018;25:3-16, tokyo-
         guidelines-2018-antimicrobial-jhbp518.pdf) · Egyptian National Drug Formulary -
         Antimicrobial 2023 (ceftriaxone monograph, p255)
Review status: REVIEWED against 2 sources listed above  (2026-08)

IS IT THIS? - reference only, to read alongside your own examination
  SYMPTOMS - what the patient reports (4)
    - The illness spans mild disease through fever, chills, feeling unwell, shaking, widespread
      belly pain, jaundice, itching, and pale stools, up to overwhelming sepsis  [abdominal pain ·
      chills · fever · itching · jaundice · malaise · pale stools · sepsis · tremor]
    - Prior gallstones, a recent gallbladder removal or ERCP, past cholangitis, or HIV/AIDS raise
      the risk of this infection  [gallstones]
    - Patients generally look markedly unwell and often present already in severe sepsis or septic
      shock  [sepsis · shock]
    - Roughly 90% of patients run a fever, and 60 to 70% are jaundiced  [fever]
  SIGNS - what you find (3)
    - Exam findings can include fever, tenderness in the upper right belly, jaundice, a distended
      abdomen, confusion, or unstable blood pressure  [abdominal distension · confusion · fever ·
      jaundice]
    - The Charcot triad of fever, right-upper-belly pain, and jaundice is very specific (95.9%) but
      misses most cases (26.4% sensitive)  [abdominal pain · fever · jaundice]
    - Adding confusion and sepsis to the classic triad forms the Reynolds pentad  [confusion ·
      sepsis]
  TESTS (10)
    - The 2018 Tokyo criteria catch essentially every case (100% sensitive) and are far more
      specific (87.4%) than the classic triad
    - Tokyo diagnosis needs two of the three classic findings plus signs of systemic inflammation,
      abnormal liver tests, and imaging showing duct dilatation with a cause such as stones or
      strictures
    - A high neutrophil count is typical, while a low white count instead shows up in septic or
      immunocompromised patients
    - Liver tests show a blocked-flow pattern with raised bilirubin, alkaline phosphatase, and GGT
    - Abdominal ultrasound is the first imaging test ordered and is highly accurate for the
      gallbladder and duct dilatation
    - A normal ultrasound does not exclude ascending infection of the bile ducts
    - Thickened duct walls, dilated ducts including the common bile duct, gallstones, and pus are
      the classic ultrasound picture
    - CT scanning is poor at picking up stones lodged in the common bile duct
    - MRCP is the best noninvasive test for finding common bile duct stones
    - ERCP both pinpoints the blockage and treats it, and allows biopsy or culture samples to be
      taken
  IF NOT THIS - what else fits (2)
    - Other liver and biliary disease to rule out includes acute cholecystitis, hepatitis,
      cirrhosis, liver failure, or a hepatic abscess
    - Other abdominal and systemic causes to exclude include pancreatitis, a perforated ulcer,
      appendicitis, diverticulitis, a kidney infection, gut ischemia, or sepsis from elsewhere
  Source  StatPearls "Cholangitis" - disease-level clinical article
  Status  traced to the source above

Rx: Empirical antibiotic started before urgent biliary drainage  |  Main treatment

EMPIRICAL ANTIBIOTIC STARTED BEFORE URGENT BILIARY DRAINAGE
1. CEFTRIAXONE                                            [1st line]
   Adult    1 to 2 g intravenously or intramuscularly, once daily or divided into two doses. Maximum
            4 g daily, and no more than 2 g daily where renal and hepatic impairment are present
            together. - Continued in hospital: 4 to 7 days once the source of infection has been
            controlled, and a minimum of 2 weeks if there is bacteraemia with a gram-positive coccus
            such as Enterococcus or Streptococcus
   Peds     50-75 mg/kg/dose  [child max 1000 mg]
            (The Egyptian formulary gives 50 to 75 mg/kg as a single daily
            dose for mild to moderate infection in infants, children and
            adolescents, with a daily ceiling of 1,000 mg - and because it is
            given once a day, that ceiling is also the ceiling on the single
            dose. For severe infection the same monograph gives 100 mg/kg per
            day divided every 12 to 24 hours to a maximum of 4,000 mg a day,
            and a premature or term neonate is given 50 mg/kg every 24 hours.
            Acute cholangitis in a child is rare and is usually a complication
            of previous biliary surgery; which of those bands applies is a
            judgement for the admitting team.)
            3kg -> 150-225 mg/dose                   4kg -> 200-300 mg/dose
            5kg -> 250-375 mg/dose                   6kg -> 300-450 mg/dose
            7kg -> 350-525 mg/dose                   8kg -> 400-600 mg/dose
            9kg -> 450-675 mg/dose                   10kg -> 500-750 mg/dose
            11kg -> 550-825 mg/dose                  12kg -> 600-900 mg/dose
            13kg -> 650-975 mg/dose                  14kg -> 700-1000 mg/dose (upper capped)
            15kg -> 750-1000 mg/dose (upper capped)  16kg -> 800-1000 mg/dose (upper capped)
            17kg -> 850-1000 mg/dose (upper capped)  18kg -> 900-1000 mg/dose (upper capped)
            19kg -> 950-1000 mg/dose (upper capped)  20kg -> 1000 mg/dose (capped)
            21kg -> 1000 mg/dose (capped)            22kg -> 1000 mg/dose (capped)
            23kg -> 1000 mg/dose (capped)            24kg -> 1000 mg/dose (capped)
            25kg -> 1000 mg/dose (capped)            26kg -> 1000 mg/dose (capped)
            27kg -> 1000 mg/dose (capped)            28kg -> 1000 mg/dose (capped)
            29kg -> 1000 mg/dose (capped)            30kg -> 1000 mg/dose (capped)
            31kg -> 1000 mg/dose (capped)            32kg -> 1000 mg/dose (capped)
            33kg -> 1000 mg/dose (capped)            34kg -> 1000 mg/dose (capped)
            35kg -> 1000 mg/dose (capped)            36kg -> 1000 mg/dose (capped)
            37kg -> 1000 mg/dose (capped)            38kg -> 1000 mg/dose (capped)
            39kg -> 1000 mg/dose (capped)            40kg -> 1000 mg/dose (capped)
            41kg -> 1000 mg/dose (capped)            42kg -> 1000 mg/dose (capped)
            43kg -> 1000 mg/dose (capped)            44kg -> 1000 mg/dose (capped)
            45kg -> 1000 mg/dose (capped)            46kg -> 1000 mg/dose (capped)
            47kg -> 1000 mg/dose (capped)            48kg -> 1000 mg/dose (capped)
            49kg -> 1000 mg/dose (capped)            50kg -> 1000 mg/dose (capped)
   AWaRe    WATCH group - carries resistance cost. Egyptian EML 2025.
   Source   Egyptian National Drug Formulary - Antimicrobial 2023 (ceftriaxone monograph, p255)
   Why      Two documents, each for a different claim. The Tokyo Guidelines 2018 name the agent: for
            grade I and grade II community-acquired acute cholangitis their cephalosporin-based
            options are cefazolin, cefotiam, cefuroxime, ceftriaxone or cefotaxime, and they state
            that antimicrobial therapy should be started before any percutaneous, endoscopic or
            operative drainage is performed - which is what makes a first dose in the clinic, on the
            way to hospital, the right move rather than a delay. The Egyptian formulary supplies the
            amount: it lists community-acquired intra-abdominal infection among ceftriaxone's
            indications and gives a general adult intravenous or intramuscular dose of 1 to 2 g once
            or twice daily. Egypt registers eight ceftriaxone injection products.
   Caution  THIS IS FOR ACUTE ASCENDING BACTERIAL CHOLANGITIS, NOT FOR THE AUTOIMMUNE DISEASES OF
            THE SAME NAME. Primary biliary cholangitis and primary sclerosing cholangitis are long-
            term hepatology conditions and no antibiotic is given for them.
            THE ANTIBIOTIC DOES NOT REPLACE THE DRAINAGE, AND MUST NOT DELAY IT. The Tokyo
            Guidelines state that antimicrobial therapy should be started before any percutaneous,
            endoscopic or operative procedure - which means the first dose goes in on the way to
            hospital, not instead of going.
            CEFTRIAXONE IS ON THE GUIDELINE'S OWN RESISTANCE LIST. The Tokyo Guidelines carry
            ceftriaxone and cefotaxime in a table of agents with a high prevalence of resistance
            among Enterobacteriaceae, reflecting the global spread of extended-spectrum beta-
            lactamase producers. Where a local antibiogram shows that resistance, the guideline's
            answer is a carbapenem, piperacillin with tazobactam, or ceftazidime or cefepime
            combined with metronidazole. What the resistance rate is in any given Egyptian hospital
            is a local measurement, and no national figure is claimed for it.
            ANAEROBIC COVER IS ADDED IF THERE IS A BILIARY-ENTERIC ANASTOMOSIS - a previous
            operation joining bile duct to bowel. The Tokyo Guidelines warrant metronidazole,
            tinidazole or clindamycin in that situation only, and note that carbapenems,
            piperacillin with tazobactam, ampicillin with sulbactam, cefmetazole, cefoxitin,
            flomoxef and cefoperazone with sulbactam already have enough anti-anaerobic activity on
            their own. The Egyptian formulary's metronidazole monograph states no dosing regimen, so
            no amount is printed here.
            AMPICILLIN WITH SULBACTAM IS NOT AN EMPIRICAL CHOICE unless the local susceptibility is
            80% or better - the Tokyo Guidelines withdraw it below that.
            REYNOLDS' PENTAD IS CHARCOT'S TRIAD PLUS HYPOTENSION AND CONFUSION, and is a surgical or
            gastroenterological emergency. Charcot's triad is fever, jaundice and right upper
            quadrant pain.
            Do not give in hypersensitivity to ceftriaxone, any component, or another cephalosporin.
            Do not give with an intravenous calcium-containing solution in a neonate of 28 days or
            less, and do not give to a jaundiced neonate, particularly a premature one, because
            ceftriaxone displaces bilirubin from albumin.
            Blood cultures before the first dose where that is possible, because the duration
            depends on what grows: a gram-positive coccus in the blood turns a 4 to 7 day course
            into a minimum of 2 weeks.
   Egypt    ZOXIDEL 1 GM PD. FOR I.M. INJ.   RAMEDA > DELT...    22.00 EGP
            CEFTRIAXONE SODIUM 1 GM I.M.VIAL (KAHIRA) KAHIRA                               29.00 EGP
            ZOXIDEL 1 GM PD. FOR I.V. INJ.   RAMEDA > DELT...    29.00 EGP
            WINTRIAXONE 1 GM PD. FOR I.V INJ. SANOFI                                       48.00 EGP
            VOTRIAXONE 1 GM I.M VIAL         CHEMIPHARM          56.00 EGP
            OFRAMAX 1 GM I.M. VIAL           RAMEDA > SUN ...    71.00 EGP
            TRIAXONE 1 GM I.M. VIAL          TABUK PHARMAC...   106.00 EGP
            TRIAXONE 1 GM I.V VIAL           TABUK PHARMAC...   106.00 EGP


MAIN TREATMENT
2. REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)            [1st line]
   Adult    Covers acute ascending (bacterial) cholangitis — fever, jaundice, right upper quadrant
            pain — a biliary emergency needing same-day hospital admission for IV antibiotics and
            urgent biliary drainage (ERCP), as well as chronic autoimmune cholangitis (primary
            biliary cholangitis / primary sclerosing cholangitis) managed long-term with
            ursodeoxycholic acid under hepatology. GP starts empirical oral antibiotics only as a
            holding measure before urgent transfer for the acute form. - Refer, with advice
   Peds     Children follow the same pathway: recognise and refer. No primary-care medicine is
            implied.
   Source   No dose - referral pathway, no medicine given in primary care
   Why      Covers acute ascending (bacterial) cholangitis — fever, jaundice, right upper quadrant
            pain — a biliary emergency needing same-day hospital admission for IV antibiotics and
            urgent biliary drainage (ERCP), as well as chronic autoimmune cholangitis (primary
            biliary cholangitis / primary sclerosing cholangitis) managed long-term with
            ursodeoxycholic acid under hepatology. GP starts empirical oral antibiotics only as a
            holding measure before urgent transfer for the acute form.
   Caution  Reynolds' pentad is Charcot's triad plus hypotension and confusion, and is a surgical or
            GI emergency.
            The drug rows above are what the treating service gives. They are here so that the
            referral is an informed one and so the GP can recognise the regimen the patient comes
            back on - not as permission to start it without the referral.
            Charcot's triad is fever, jaundice, and right upper quadrant pain.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.
```

---

Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement.

[Privacy policy](/privacy)
